Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06096051 · ClinicalTrials.gov registry record
Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 76
- Enrollment target
NCT06096051: Completed study, sponsored by Methodist Health System.
NCT06096051 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 76 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06096051 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
Intracranial hemorrhage (ICH) can occur due to traumatic and spontaneous events.1 The incidence of non-traumatic, spontaneous ICH is approximately 40,000 to 67,000 cases per year while the incidence of traumatic brain injury (TBI) is nearly 1.7 million annually
Primary Outcome
fixed-dose 4F-PCC is safe and effective in patients with DOAC-associated ICH when compared to weight-based dosing.
Interventions
- PROCEDURE Use of fixed-dosed 4F-PCC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2023-06-13 |
| Est. Completion | 2024-06-17 |
What the finished NCT06096051 record still lists
NCT06096051 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Use of fixed-dosed 4F-PCC is the first listed.
NCT06096051 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06096051 about?
NCT06096051 is a clinical study titled "Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage". Intracranial hemorrhage (ICH) can occur due to traumatic and spontaneous events.1 The incidence of non-traumatic, spontaneous ICH is approximately 40,000 to 67,000 cases per year while the incidence of traumatic brain injury (TBI) is nearly 1.7 million annually
What is the current status of trial NCT06096051?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2023-06-13. Estimated completion is 2024-06-17.
What interventions are being tested in trial NCT06096051?
The interventions under investigation include: Use of fixed-dosed 4F-PCC (PROCEDURE).
Who is sponsoring clinical trial NCT06096051?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI